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Multi-arm multi-stage (MAMS) designs can greatly
increase the speed and efficiency of treatment evaluation
compared to separate trials of each new therapy. A class
of MAMS designs with stopping guidelines only for
lack-of-benefit have been developed for time-to-event
outcomes and have been used to design several trials in
oncology. In these designs, interim assessments can be
made on an intermediate outcome which is on the cau-
sal pathway to the definitive primary outcome of the
trial. Such designs can therefore incorporate both phase
II and phase III in a single trial, further increasing the
efficiency of treatment evaluation.
Tuberculosis (TB) is treated with combination regimens
and, with many new or repurposed drugs currently in
clinical development, better designs are needed to facili-
tate simultaneous testing of several new regimens in a
single trial. To allow use of MAMS designs, we extend
the methodology to binary outcomes, which are often
used in TB trials.
We present methods for finding MAMS designs which
have the desired pairwise type I error rate and power.
Since there may be many such designs, choosing which
to use can be tricky, as those which minimise the maxi-
mum or expected sample size are likely to perform
poorly in practice. Designs which balance the two mea-
sures, known as admissible designs, may therefore be
more appealing.
We give examples of admissible MAMS TB designs
and demonstrate the savings in time and resources that
could be made over conducting separate trials, particu-
larly when using them to design seamless phase II/III
trials.
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